Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juan Fueyo

Showing results (1-10 of 109) with videos related to

Pageof 11
Sort By:
Discovery Medicine|July 31, 2010
Eradication of brain tumor stem cells with an oncolytic adenovirusHong Jiang, Juan Fueyo
Oncoimmunology|May 9, 2015
Healing after death: antitumor immunity induced by oncolytic adenoviral therapyHong Jiang, Juan Fueyo
Current Opinion in Molecular Therapeutics|October 2, 2010
Oncolytic adenoviruses for the treatment of brain tumorsCandelaria Gomez-Manzano, Juan Fueyo
Neurosurgical Focus|February 1, 2021
Delta-24 adenoviral therapy for glioblastoma: evolution from the bench to bedside and future considerationsChibawanye I Ene, Juan Fueyo, Frederick F Lang
Archives of Neurology|November 10, 2010
Advances in translational research in neuro-oncologyJuan Fueyo, Candelaria Gomez-Manzano, W K Alfred Yung
Cancer Letters|March 13, 2008
E2F1 in gliomas: a paradigm of oncogene addictionMarta M Alonso, Ramon Alemany, Juan Fueyo, et al.
Autophagy|November 23, 2007
Adenovirus's last trick: you say lysis, we say autophagyHong Jiang, Erin J White, Candelaria Gomez-Manzano, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 28, 2011
Targeting brain tumor stem cells with oncolytic adenovirusesMarta M Alonso, Hong Jiang, Candelaria Gomez-Manzano, et al.
International Journal of Oncology|October 9, 2002
Overexpression of E2F-1 leads to bax-independent cell death in human glioma cellsParaskevi G Mitlianga, Candelaria Gomez-Manzano, Athanassios P Kyritsis, et al.
Neurology|August 12, 2004
Genetically modified adenoviruses against gliomas: from bench to bedsideCandelaria Gomez-Manzano, W K Alfred Yung, Ramon Alemany, et al.
Pageof 11

Showing results (1-10 of 109) with videos related to

Sort By:
Pageof 11
Discovery Medicine|July 31, 2010
Eradication of brain tumor stem cells with an oncolytic adenovirusHong Jiang, Juan Fueyo
Oncoimmunology|May 9, 2015
Healing after death: antitumor immunity induced by oncolytic adenoviral therapyHong Jiang, Juan Fueyo
Current Opinion in Molecular Therapeutics|October 2, 2010
Oncolytic adenoviruses for the treatment of brain tumorsCandelaria Gomez-Manzano, Juan Fueyo
Neurosurgical Focus|February 1, 2021
Delta-24 adenoviral therapy for glioblastoma: evolution from the bench to bedside and future considerationsChibawanye I Ene, Juan Fueyo, Frederick F Lang
Archives of Neurology|November 10, 2010
Advances in translational research in neuro-oncologyJuan Fueyo, Candelaria Gomez-Manzano, W K Alfred Yung
Cancer Letters|March 13, 2008
E2F1 in gliomas: a paradigm of oncogene addictionMarta M Alonso, Ramon Alemany, Juan Fueyo, et al.
Autophagy|November 23, 2007
Adenovirus's last trick: you say lysis, we say autophagyHong Jiang, Erin J White, Candelaria Gomez-Manzano, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 28, 2011
Targeting brain tumor stem cells with oncolytic adenovirusesMarta M Alonso, Hong Jiang, Candelaria Gomez-Manzano, et al.
International Journal of Oncology|October 9, 2002
Overexpression of E2F-1 leads to bax-independent cell death in human glioma cellsParaskevi G Mitlianga, Candelaria Gomez-Manzano, Athanassios P Kyritsis, et al.
Neurology|August 12, 2004
Genetically modified adenoviruses against gliomas: from bench to bedsideCandelaria Gomez-Manzano, W K Alfred Yung, Ramon Alemany, et al.
Pageof 11